SW increased glucose consumption by activating the PI3K/AKT pathway in HepG2 cells, thereby ameliorating dexamethasone-induced insulin resistance and exerting a hypoglycemic effect [61]. This evidence concerns the gene AKT1 and Insulin resistance.